Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

The National Law Review
natlawreview.com > press-releases > definium-therapeutics-discuss-topline-results-phase-3-panorama-study

Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026

6+ hour ago   (484+ words) Definium Therapeutics to Discuss Topline Results from Phase 3 Pan The National Law Review Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026 Company to host webcast tomorrow at 8:00 a.m. EDT NEW YORK--(BUSINESS WIRE)…...

Asian Business Review
asianbusinessreview.com > commentary > eastward-shift-in-biotech-world-why-india-and-china-could-lead-next-wave

The eastward shift in the biotech world: Why India and China could lead the next wave

8+ hour, 38+ min ago   (747+ words) China’s advantage is scale across discovery and development, and India in cost-efficiency and innovation footprint. For decades, the global biotechnology map was largely defined by a handful of established centres in the United States, and Europe. Boston, the Bay Area,…...

PharmaDispatch
pharmadispatch.com > news > melbourne-biotechs-psychedelic-infusion-keeps-binge-eating-disorder-at-bay-three-months-after-tr

Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends

6+ hour, 24+ min ago   (131+ words) PharmaDispatch Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an experimental psychedelic drug....

marker movers & expertise.
sharecafe.com.au > 09/14/2026 > daily-special-healthco-healthcare-wellness-reit-proteomics-international-laboratories-titomic-green360-technologies-tmk-energy

Daily Special: HealthCo Healthcare & Wellness REIT, Proteomics International Laboratories, Titomic, Green360 Technologies, TMK Energy

6+ hour, 44+ min ago   (29+ words) Sharecafe Daily Special: HealthCo Healthcare & Wellness REIT, Proteomics International Laboratories, Titomic, Green360 Technologies, TMK Energy...

@IntellectiaAI
intellectia.ai > news > stock > definiums-dt120-study-shows-significant-progress

Definium's DT120 Study Shows Significant Progress

7+ hour, 28+ min ago   (7+ words) intellectia.ai...

The Sentinel
sentinelnews.com.au > health-wellbeing > trial-results-offers-new-hope-for-heart-patients

Trial results offers new hope for heart patients - The Sentinel News

10+ hour, 13+ min ago   (68+ words) Trial results offers new hope for heart patients sentinelnews.com.au Trial results offers new hope for heart patients Ramping falls to six-year low The rise of anti-vaccine activism and the fall of child immunisation Sardinemaxxing is no fishy fad…...

FirstWord Pharma
firstwordpharma.com > story > 7985869

Spotlight On: Ivonescimab beats expectations to revive practice-changing hopes in NSCLC

11+ hour, 26+ min ago   (13+ words) FirstWord Pharma...

Oncodaily - Oncology News
oncodaily.com > voices > servier-585580

Servier Partnering Day: Connecting Pharma, Biotech, and Academia for New Opportunities - OncoDaily

12+ hour, 44+ min ago   (107+ words) Servier shared on LinkedIn: “We are excited to announce that the next edition of the Servier Partnering Day will take place in our Paris-Saclay R/D Institute on November 23rd! This unique event is designed to bring together pharma and biotech…...

StocksToTrade
stockstotrade.com > news > edgewisetherapeuticsinc-ewtx-news-2026_09_13

Edgewise Therapeutics Jumps As EDG-7500 Data Fuels Bullish Target Hike

18+ hour, 1+ min ago   (395+ words) Edgewise Therapeutics Inc. stocks have been trading up by 7.32 percent following highly positive clinical trial advancement news. What Traders Need To Know JPMorgan lifted its price target to $60 from $53 and kept an Overweight rating after updating its model following Edgewise…...

indica News
indicanews.com > ai-researchers-explore-fine-tuning-foundation-models-for-biology-and-drug-discovery

AI researchers explore fine-tuning foundation models for biology and drug discovery

1+ day, 3+ hour ago   (62+ words) indica News Adapting foundation models to the complexities of human biology is emerging as a new frontier in artificial intelligence-driven health care, researchers and industry executives said at a recent panel discussion in San Carlos, California... To continue reading, please…...